544 published articles on BPC 157. 36 met inclusion criteria for a 2025 systematic review. 35 were animal studies. One was clinical. Twelve patients. Seven reported pain relief. No control group. That is BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC 157 And TB 500 for Women: Benefits, Risks, and Safer Alternatives BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & Peptides for Surgery Recovery: BPC 157, TB 500 & More Surgeon's Guide Bpc 157 ( Body Protection Compound 157 ) Pentadecapeptide Dosage Form: Powder at Best Price in Shenzhen Sino Kingtop Pharm Co.,ltd.